This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Outcomes of Treatment for Infective Endocarditis Following Transcatheter Pulmonary Valve Replacement

Tuesday, February 28, 2023

Submitted by


Source Name: World Journal for Pediatric and Congenital Heart Surgery


Fox JC, Carvajal HG, Wan F, Canter MW, Merritt TC, Eghtesady P.

Transcatheter pulmonary valve replacement (TPVR) carries an increased risk of infective endocarditis. This study used data from the Pediatric Health Information System for the period 2010–2020. Ninety-eight hospital admissions for infective endocarditis were identified for sixty-eight patients. For index admissions, 78 percent were treated medically and 22 percent surgically. The need for surgical intervention increased with increasing need for readmission. Mortality was 4.3 percent overall. Concern was expressed that reliance on medical therapy may delay surgery, which in this cohort was more successful overall.

Add comment

Log in or register to post comments